Wednesday, November 22, 2017

Archive for the Category ‘Featured’

Uncovering the Billion Dollar Potential in VIVUS (HGSI, DNDN, SOMX, NTRI, MED, VVUS, OREX, ARNA)

Uncovering the Billion Dollar Potential in VIVUS (HGSI, DNDN, SOMX, NTRI, MED, VVUS, OREX, ARNA)

Cinderella stories within the biotech industry are hard to come by these days, especially considering the difficulty of attaining FDA approval while attempting to maintain a steady balance of cash on hand. Dilution, false promises and hopes run rampant during the recent renewed financial crisis. There are, however, success stories which seem to trump the […]

Third Depression Looming: Printing U.S. Dollars, Buying Futures and Cranking Up Mainstream Media

Third Depression Looming: Printing U.S. Dollars, Buying Futures and Cranking Up Mainstream Media

Ever since the S&P 500 dipped below the landmark support at 1060, it has become increasingly evident that the Federal Reserve, along with hedge funds, institutions and banks have been keen on playing games with retail investors in order to stir up false hopes that a recovery may be on the way. Well, guess what, […]

Financial Armageddon Is Here, Financial Bear 3x ETF Rejoice

Financial Armageddon Is Here, Financial Bear 3x ETF Rejoice

Looks like the bulls will be frying on a wooden stick via the bears bond-fire as of early morning Tuesday, June, 29, 2010, especially considering the bloody massacre that took place in our World Markets: China and Europe. Fears on the World Bank’s statement that economic growth in China would slow caused panic worldwide, and […]

S&P 500 Will Continue To Crash, While Direxion Bear 3x ETF Surges

S&P 500 Will Continue To Crash, While Direxion Bear 3x ETF Surges

With the continued pessimism on economic outlook and future data, there currently sits no better investment on the table other than Direxion Financial Bear 3x ETF (NYSE:FAZ), and the obvious choice, Gold ETF (NYSE:GLD). While numerous reports have surfaced recently that several polled Wall Street analysts foresee a rise of 13% in the S&P 500 […]

U.S. Media Is Making A Fool Out Of Financial Traders

U.S. Media Is Making A Fool Out Of Financial Traders

It seems like the Feds and their relentless pursuit of a speedy economic recovery have pointed their direction towards the mass U.S. media in order to capitalize on the slow June trading month. Major banks rallied by the bunches, with the likes of Citigroup (NYSE:C), Bank of America (NYSE:BAC), JPMorgan Chase (NYSE:JPM), Goldman Sachs (NYSE:GS), […]

US Banks Under Fire: Citigroup, Bank Of America, JPMorgan Chase, Goldman Sachs, American International, Wells Fargo, Morgan Stanley

US Banks Under Fire: Citigroup, Bank Of America, JPMorgan Chase, Goldman Sachs, American International, Wells Fargo, Morgan Stanley

The 3x Financial Bear ETF (NYSE:FAZ) has never looked so juicy, especially with the prepped up, fake financial rally created by sleazy, lying, and manipulative US government regulators as they issued numerous, erroneous headlines in order to hide the truth from the public’s eye. Bank stocks will be the first to feel the burn as […]

Hana Biosciences: The Perfect ASCO Conference Investment Opportunity

Hana Biosciences: The Perfect ASCO Conference Investment Opportunity

Hana Biosciences, Inc. (OTC:HNAB) Comparisons: AspenBio Pharma (NASDAQ:APPY), Somaxon (NASDAQ:SOMX), Cell Therapeutics (NASDAQ:CTIC), Delcatch Systems (NASDAQ:DCTH). * Full article requires membership, visit our subscriptions page to become a member Amidst an uncertain market, Hana Biosciences has positioned itself nicely for the upcoming ASCO conference on June, 7th, 2010, where it will present its phase 2 […]

Discovery Laboratories: Small Biotech Company With Multiple Prime Time Catalysts

Discovery Laboratories: Small Biotech Company With Multiple Prime Time Catalysts

Discovery Laboratories, Inc. This report is on (NASDAQ:DSCO), and also includes the following companies: Johnson & Johnson (NYSE:JNJ), Merck & Co. (NYSE:MRK), Pfizer (NYSE:PFE), Somaxon (NASDAQ:SOMX), Hemispherx (AMEX:HEB), AspenBio Pharma (NASDAQ:APPY), and AEterna Zentaris (NASDAQ:AEZS). Without a doubt, this past year the biotech industry has been characterised by companies who’ve found ways to persevere past […]

AEterna Zentaris: Uncovering The Next Dominant Cancer Company

AEterna Zentaris: Uncovering The Next Dominant Cancer Company

AEterna Zentaris Inc. (NASDAQ:AEZS) The oncology focused companies, led by Dendreon (NASDAQ:DNDN) and Human Genome (NASDAQ:HGSI) have become the biotechnology and drugs sector’s hottest new fad, stealing the spotlight and making once average Joes trading in the $2 range, into, now, Hollywood stock market Broadway stars. With their names forged in stone for us to […]

Is AspenBio Pharma Next To Follow In The Footsteps Of Dendreon and Human Genome Sciences?

Is AspenBio Pharma Next To Follow In The Footsteps Of Dendreon and Human Genome Sciences?

AspenBio Pharma, Inc. (Public, NASDAQ:APPY) AspenBio Pharma is about the embark on the most critical journey the company has ever faced since inception, with three important company developments awaiting announcements all within the next two weeks. At the forefront is the pivotal, stand alone 800 patient clinical trial result which is due in the first […]

Back to Top

Social Media Profiles

ADVERTISEMENT

BUSINESS NETWORKS

The New York Times logo CNN logo ABC logo CNBC logo